100.00% -0.0002

Effector Therapeutics Inc (EFTR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Effector Therapeutics Inc Azioni (EFTR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	2.35% 8.396	8.598	7.855	7.855	9.536
Interest Income/Expense	1.19% 0.749	0.758	0.75	0.722	0.689
Depreciation and Amortization	99.97% 0.028	110.92	0.026	0.027	0.028
Operating Income/Loss	2.35% -8.396	-8.598	-7.855	-7.855	-9.536
Nonoperating Income/Loss	17.67% -0.438	-0.532	-0.448	-0.509	-0.478
Income/Loss From Continuing Operations Before Tax	3.24% -8.834	-9.13	-8.303	-8.364	-10.01
Income/Loss From Continuing Operations After Tax	3.24% -8.834	-9.13	-8.303	-8.364	-10.01
Net Income/Loss	3.24% -8.834	-9.13	-8.303	-8.364	-10.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	108.43% 4.0816	-48.42	61.77	47.83	42.00
Diluted Average Shares	108.43% 4.0816	-48.42	61.77	47.83	42.00
Basic Earnings Per Share	86.36% -2.16	-15.84	-0.13	-0.17	-0.24
Diluted Earnings Per Share	86.36% -2.16	-15.84	-0.13	-0.17	-0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INSM

$98.73

1.91%

GMAB

$22.82

1.17%

RPRX

$34.84

1.22%

SMMT

$19.78

1.88%

BNTX

$106.57

1.57%

ONC

$269.63

2.50%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto su Reuters